Huaxiang Wu Selected Research

Huaxiang Wu Research Topics

Disease

11	Rheumatoid Arthritis 09/2023 - 08/2013
9	Gout 11/2023 - 07/2014
6	Ankylosing Spondylitis 03/2022 - 03/2014
5	Systemic Lupus Erythematosus (Libman-Sacks Disease) 01/2023 - 11/2019
2	Hyperuricemia 05/2024 - 01/2020
2	Fibrosis (Cirrhosis) 03/2024 - 01/2022
2	Inflammation (Inflammations) 01/2023 - 03/2019
2	Spondylarthropathies 03/2022 - 10/2013
2	Arthritis (Polyarthritis) 07/2019 - 03/2017
2	Gouty Arthritis 03/2017 - 07/2014
1	Metabolic Syndrome (Dysmetabolic Syndrome X) 05/2024
1	Macrophage Activation Syndrome 11/2023
1	Pulmonary Fibrosis (Fibrosing Alveolitis) 11/2023
1	Axial Spondyloarthritis 09/2023
1	Tuberculosis (Tuberculoses) 01/2023
1	Starvation 01/2023
1	Insulin Resistance 12/2022
1	Chronic Renal Insufficiency 10/2022
1	Dermatomyositis (Dermatopolymyositis) 01/2022
1	Systemic Scleroderma (Systemic Sclerosis) 01/2022
1	Osteoarthritis 01/2022
1	Lung Diseases (Lung Disease) 01/2022
1	Antisynthetase syndrome 01/2022
1	Respiratory Tract Infections (Respiratory Tract Infection) 01/2022
1	Chronic Disease (Chronic Diseases) 01/2022
1	Interstitial Lung Diseases (Interstitial Lung Disease) 01/2022
1	Fatigue 01/2022
1	Behcet Syndrome (Behcet's Syndrome) 12/2021
1	Autoimmune Diseases (Autoimmune Disease) 02/2021
1	Disease Progression 01/2021
1	Sjogren's Syndrome (Sjogren Syndrome) 01/2021
1	Insulinoma 01/2020
1	Back Pain (Backache) 01/2020
1	Experimental Arthritis 07/2019
1	Joint Diseases (Joint Disease) 10/2013
1	Lipoma (Lipomata) 10/2013

Drug/Important Bio-Agent (IBA)

10	Uric Acid (Urate)IBA 11/2023 - 07/2014
6	Biosimilar PharmaceuticalsIBA 10/2022 - 01/2020
5	Biomarkers (Surrogate Marker)IBA 09/2023 - 01/2020
4	Adalimumab (Humira)FDA Link 03/2022 - 03/2014
3	Immunoglobulins (Immunoglobulin)IBA 02/2021 - 01/2018
2	MicroRNAs (MicroRNA)IBA 11/2023 - 01/2022
2	Antirheumatic Agents (DMARD)IBA 09/2023 - 10/2013
2	Semaphorins (Semaphorin)IBA 03/2023 - 01/2022
2	Rituximab (Mabthera)FDA Link 01/2023 - 10/2022
2	GlucocorticoidsIBA 01/2023 - 12/2021
2	Methotrexate (Mexate)FDA LinkGeneric 10/2022 - 03/2019
2	ametantrone (HAQ)IBA 03/2022 - 01/2022
2	Interleukin-6 (Interleukin 6)IBA 01/2022 - 01/2020
2	Etanercept (Enbrel)FDA Link 03/2021 - 01/2020
2	Long Noncoding RNAIBA 01/2021 - 01/2021
2	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 10/2013 - 08/2013
1	Anthocyanins (Anthocyanin)IBA 05/2024
1	AntioxidantsIBA 05/2024
1	FlavonoidsIBA 05/2024
1	Bleomycin (Blenoxane)FDA LinkGeneric 03/2024
1	Interferon Type IIBA 11/2023
1	Colchicine FDA LinkGeneric 11/2023
1	Interleukin-17 (Interleukin 17)IBA 09/2023
1	ixekizumabIBA 09/2023
1	Tumor Necrosis Factor InhibitorsIBA 09/2023
1	Leflunomide (Arava)FDA LinkGeneric 01/2023
1	Cell-Free Nucleic AcidsIBA 01/2023
1	NitrogenIBA 01/2023
1	Pancreatic Elastase (Elastase)IBA 01/2023
1	Immunosuppressive Agents (Immunosuppressants)IBA 01/2023
1	CytokinesIBA 01/2023
1	Tacrolimus (Prograf)FDA LinkGeneric 01/2023
1	Calcium Carbonate (Limestone)FDA Link 01/2023
1	Leukocyte Elastase (Neutrophil Elastase)IBA 01/2023
1	LipidsIBA 12/2022
1	Febuxostat FDA Link 10/2022
1	Proteins (Proteins, Gene)FDA Link 01/2022
1	Matrix Metalloproteinase 13IBA 12/2021
1	Azathioprine (Imuran)FDA LinkGeneric 12/2021
1	RNA (Ribonucleic Acid)IBA 01/2021
1	bergeninIBA 01/2020
1	Indicators and Reagents (Reagents)IBA 01/2020
1	Scavenger Receptors (Scavenger Receptor)IBA 01/2020
1	Small Interfering RNA (siRNA)IBA 01/2020
1	Vasoactive Intestinal Peptide (VIP (Vasoactive Intestinal Peptide))IBA 07/2019
1	CollagenIBA 07/2019
1	Certolizumab Pegol FDA Link 03/2019
1	tufulingIBA 03/2017
1	Infliximab (Remicade)FDA Link 08/2013
1	Monoclonal AntibodiesIBA 08/2013

Therapy/Procedure

10	Therapeutics 01/2023 - 08/2013
1	Endovascular Procedures 11/2023
1	Remission Induction 01/2023